| 2011-09 |
DNA repair enzyme, O6-methylguanine DNa methyltransferase, modulates therapeutic efficacy of platinum drugs with radiation and its clinical significance |
European Journal of Cancer. 2011 Sep;47:S132. |
 |
| 2011-07 |
MicroRNA signature and aberrant methylation in human oral squamous cell carcinomas |
Oral Oncology. 2011 Jul;47(Suppl. 1):S92. |
|
| 2011-05 |
Pharmacokinetic study with novel anticanacer agents, MPTOB124 and MPTOB214 |
Drug Metabolism Reviews. 2011 May;43(Suppl. 1):73. |
|
| 2011-04 |
Activation of Akt/FoxO axis confers resistance to cisplatin in human nasopharyngeal carcinomas |
Cancer Research. 2011 Apr;71:Abstract number 1701. |
|
| 2011-04 |
Activation of NRF2/ABCC1 axis confers resistance to topoisomerase II poisons in human oral malignancies |
Cancer Research. 2011 Apr;71:Abstract number 1528. |
|
| 2011-04 |
MPT0B098, a novel microtubule inhibitor, displays potent anti-angiogenic activity via destabilizing hypoxia-inducible factor-1alpha mRNA |
Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 4461. |
|
| 2011-04 |
Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway |
Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 2864. |
|
| 2010-10 |
Combined modalities of resistance in a cisplatin-driven human betel-associated oral squamous cell carcinoma |
Annals of Oncology. 2010 Oct;21(Suppl. 8):52. |
|
| 2010-06 |
Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma |
Annals of Oncology. 2010 Jun;21(Suppl. 6):27. |
|
| 2009-09 |
Synergistic augmentation of arsenic trioxide-induced cytotoxicity by BCNU through reactive oxygen species-related autophagic pathway in human solid tumors |
EJC Supplements. 2009 Sep;7(3):16. |
|
| 2009-05-20 |
Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC) |
Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 4587. |
|
| 2009-05 |
Down-regulation of survivin enhances sensitivity to BPROL075 in human cancer cells via caspase-independent mechanisms |
Cancer Research. 2009 May;69:Abstract number 5542. |
|
| 2007-07 |
A novel oral indoline-sulfonamide derivative, J30, exhibits potent activity against human cancer cells both in in vitro and in vivo through disruption of microtubule |
Drugs of the Future. 2007 Jul;32(Suppl. A):35-36. |
|
| 2006-11 |
Combined modalities of resistance in an oxaliplaitin-resistant human gastric cancer cell line with enhanced sensitivity |
EJC Supplements. 2006 Nov;4(12):59. |
|
| 2006-11 |
D-501036, a novel selenophene-base triheterocycle derivative exhibits potent in vitro and in vivo anti-tumoral activity, which involves DNA-damage and ATM activation |
EJC Supplements. 2006 Nov;4(12):92. |
|
| 2006-11 |
Tamoxifen induces degradation of the o6-methylguanine DNA methyltransferase protein via the ubiquitin-dependent proteosome pathway in human cancer cells |
EJC Supplements. 2006 Nov;4(12):155. |
|
| 2006-02 |
DNA repair enzyme, O-6-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors |
Journal of Pharmacology and Experimental Therapeutics. 2006 Feb;316(2):946-954. |
|
| 2006-01 |
Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma |
Head and Neck. 2006 Jan;28(1):74-80. |
|
| 2005-12 |
Induction of cell death by a novel selenophene derivative, D-501036, in human cancer cell lines |
Clinical Cancer Research. 2005 Dec;11(24):9101S. |
|
| 2004-09 |
Drug design of BPR0L075 as an anticancer agent |
World Conference on Magic Bullets - Celebrating Paul Ehrlich's 150th Birthday. 2004 Sep 9-11:Abstract # 203. |
|
| 2004-08-02 |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer |
British Journal of Cancer. 2004 Aug;91(3):453-458. |
|
| 2004-07 |
Drug design for BPR0L075 as an anticancer agent |
Medicine in the 21st Century Tri-Conference & Bio-Forum 2004 Shanghai International Convention Center. 2004 Jul. |
|
| 2002 |
Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma |
International Journal of Cancer. 2002;Suppl. 13:336-337. |
|
